Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer

BACKGROUND: Bladder cancer (BC) is one of the most common malignant diseases and the most common causes of cancer death worldwide. Immunotherapy has opened new avenues for precision treatment of bladder tumours, and immune checkpoint inhibitors (ICIs) have revolutionized the clinical treatment strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Pengyu, Ni, Feng, Zheng, Liang, Jia, Lei, Wang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111848/
https://www.ncbi.nlm.nih.gov/pubmed/37072750
http://dx.doi.org/10.1186/s12885-023-10828-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111848/
https://www.ncbi.nlm.nih.gov/pubmed/37072750
http://dx.doi.org/10.1186/s12885-023-10828-z

Ejemplares similares